Oculis Holding AG
ICEX:OCS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Oculis Holding AG
ICEX:OCS
|
CH |
|
Fortress Biotech Inc
NASDAQ:FBIO
|
US |
|
D
|
Ducommun Inc
SWB:DUM
|
US |
|
H
|
Hanover Insurance Group Inc
XBER:AF4
|
US |
|
A
|
Aptiv PLC
SWB:D7A
|
IE |
|
Eagle Materials Inc
F:E5M
|
US |
|
P
|
PTC Inc
F:PMTA
|
US |
|
Peet Ltd
ASX:PPC
|
AU |
|
D
|
Darling Ingredients Inc
XBER:43D
|
US |
|
A
|
Aristocrat Leisure Ltd
XMUN:AC8
|
AU |
|
Schibsted ASA
F:XPG
|
NO |
Wall St Price Targets
OCS Price Targets Summary
Oculis Holding AG
According to Wall Street analysts, the average 1-year price target for OCS is 4 729.48 ISK with a low forecast of 3 059.32 ISK and a high forecast of 6 483.29 ISK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is OCS's stock price target?
Price Target
4 729.48
ISK
According to Wall Street analysts, the average 1-year price target for OCS is 4 729.48 ISK with a low forecast of 3 059.32 ISK and a high forecast of 6 483.29 ISK.